Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Lupin gets USFDA approval for generic Potassium Chloride Oral Solution

      Lupin gets USFDA approval for generic Potassium Chloride Oral Solution

      Ruby Khatun Khatun1 Sept 2018 11:00 AM IST
      The company's product is a generic version of Genus Lifesciences Inc's Potassium chloride oral solution in the same strengthsNew Delhi: Drug firm...
      Sun Pharma launches Volini Maxx with Virat Kohli as brand ambassador

      Sun Pharma launches Volini Maxx with Virat Kohli as brand ambassador

      Ruby Khatun Khatun1 Sept 2018 10:00 AM IST
      Mumbai: Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Ltd announced the launch of Volini Maxx, India’s strongest pain...
      Medical device maker Stryker to buy K2M Group for about 1.4 billion

      Medical device maker Stryker to buy K2M Group for about 1.4 billion

      Ruby Khatun Khatun1 Sept 2018 9:47 AM IST
      Medical device maker Stryker Corp said it will buy smaller rival K2M Group Holdings Inc for about $1.4 billion, adding K2M's fast-growing spinal...
      AstraZenecas experimental lupus drug fails to meet main goal in study

      AstraZeneca's experimental lupus drug fails to meet main goal in study

      Ruby Khatun Khatun1 Sept 2018 9:30 AM IST
      AstraZeneca’s experimental drug anifrolumab failed to meet its main target in a late-stage clinical study treating patients with moderate to severe...
      Canadian province sues opioid makers, distributors

      Canadian province sues opioid makers, distributors

      Ruby Khatun Khatun1 Sept 2018 9:15 AM IST
      Ottawa: The epicenter of Canada's opioid crisis, British Columbia province, sued more than 40 drug companies to recover the costs of emergency...
      Delhi Police Busts Painkiller Racket in the capital- 46,000 capsules of Tramadol Seized

      Delhi Police Busts Painkiller Racket in the capital- 46,000 capsules of Tramadol Seized

      Ruby Khatun Khatun31 Aug 2018 5:11 PM IST
      New Delhi: Delhi police crime branch has busted an inter-state group and arrested three people for illegally supplying a drug called tramadol to...
      SGLT2 inhibitors can lead to serious genital infection: USFDA warning

      SGLT2 inhibitors can lead to serious genital infection: USFDA warning

      Ruby Khatun Khatun31 Aug 2018 4:50 PM IST
      The SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
      Fortis Healthcare CFO Gagandeep Singh Bedi resigns

      Fortis Healthcare CFO Gagandeep Singh Bedi resigns

      Ruby Khatun Khatun31 Aug 2018 11:28 AM IST
      New Delhi: Fortis Healthcare on Thursday said its Chief Financial Officer Gagandeep Singh Bedi has resigned citing personal reasons.The Board of...
      Zydus Cadila gets USFDA approval to market 2 products

      Zydus Cadila gets USFDA approval to market 2 products

      Ruby Khatun Khatun31 Aug 2018 11:00 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Gemfibrozil tablets and Aripiprazole...
      Glenmark Pharma signs pact to market Tiotropium Bromide dry powder inhaler in Western Europe

      Glenmark Pharma signs pact to market Tiotropium Bromide dry powder inhaler in Western Europe

      Ruby Khatun Khatun31 Aug 2018 10:00 AM IST
      New Delhi: Glenmark Pharmaceuticals Europe has entered into a strategic, exclusive licensing agreement for marketing generic Tiotropium Bromide dry...
      Bayers hemophilia A drug gets USFDA approval

      Bayer's hemophilia A drug gets USFDA approval

      Ruby Khatun Khatun31 Aug 2018 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) approved Bayer AG's drug for the treatment of hemophilia A, a rare genetic disorder in which the blood...
      Sterilisation firm Sotera Health explores sale for nearly 5 billion dollar- sources

      Sterilisation firm Sotera Health explores sale for nearly 5 billion dollar- sources

      Ruby Khatun Khatun31 Aug 2018 9:30 AM IST
      Sotera Health, a private-equity owned company that operates facilities that sterilize medical products and food, is exploring a potential sale worth...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok